14 December 2009
Lan Chem Laboratories Completes Phase II Study with APD405 in Post-Operative Nausea & Vomiting (PONV)
14 December 2009
Lan Chem Laboratories Completes Phase II Study with APD405 in Post-Operative Nausea & Vomiting (PONV)08 June 2009
Lan Chem Laboratories Initiates Phase II Study with APD405 in Post-Operative Nausea & Vomiting (PONV)31 March 2009
Lan Chem Laboratories Initiates Phase IIa Study with APD209 in Cancer Cachexia Patients05 February 2009
Ian Kent Appointed as Chairman